Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Has China Won?
The defining geopolitical contest of the twenty-first century is between China and the US. But is it avoidable? And if it happens, is the outcome already inevitable? China and America are world powers without serious rivals. They eye each other warily across the Pacific; they communicate poorly; there seems little natural empathy. A massive geopolitical contest has begun. America prizes freedom; China values freedom from chaos.America values strategic decisiveness; China values patience.America is becoming society of lasting inequality; China a meritocracy.America has abandoned multilateralism; China welcomes it. Kishore Mahbubani, a diplomat and scholar with unrivalled access to policymakers in Beijing and Washington, has written the definitive guide to the deep fault lines in the relationship, a clear-eyed assessment of the risk of any confrontation, and a bracingly honest appraisal of the strengths and weaknesses, and superpower eccentricities, of the US and China.
The Weekly Reporter
With v. 26 is bound: A general digest of criminal cases reported in the Weekly reporter. By D. E. Cranenburgh. Calcutta, 1893.
The Law of Landlord and Tenant
Reprint of the original, first published in 1874.
The Indian Digest
None
Company law
None
Progress in Medicinal Chemistry
There are five main subject areas in this volume in the series on medicinal chemistry. The first is a review of the understanding of Alzheimer's disease and the development of drugs for its treatment; the second, looking at recent efforts in modifying a naturally occuring anticancer (campothecin) for chemotherapy; the third covers the problem of getting a drug to a specific site within the context of phosphates and phosphonates; a survey of sterilization using aldehydes for the destruction of microbes both inside and outside the human body is reviewed in the fourth; and the last chapter is an account of the progress made in the biologically active enantiomer for complex synthetic asymmetric drug molecules.
